ELTX
Elicio Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Robert T. Connelly
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Elicio Therapeutics, Inc.
CEO
Robert T. Connelly
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US